chr11-122977657-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001098169.2(BSX):ā€‹c.694G>Cā€‹(p.Val232Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000831 in 1,608,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00047 ( 0 hom., cov: 33)
Exomes š‘“: 0.00087 ( 0 hom. )

Consequence

BSX
NM_001098169.2 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.64
Variant links:
Genes affected
BSX (HGNC:20450): (brain specific homeobox) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including eating behavior; mammary gland involution; and positive regulation of transcription by RNA polymerase II. Predicted to be located in cytoplasm. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.01973465).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BSXNM_001098169.2 linkuse as main transcriptc.694G>C p.Val232Leu missense_variant 3/3 ENST00000343035.3
LOC124902774XR_007062926.1 linkuse as main transcript downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BSXENST00000343035.3 linkuse as main transcriptc.694G>C p.Val232Leu missense_variant 3/35 NM_001098169.2 P1

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152228
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000941
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000392
AC:
95
AN:
242628
Hom.:
0
AF XY:
0.000377
AC XY:
50
AN XY:
132466
show subpopulations
Gnomad AFR exome
AF:
0.000199
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000420
Gnomad NFE exome
AF:
0.000721
Gnomad OTH exome
AF:
0.000500
GnomAD4 exome
AF:
0.000868
AC:
1264
AN:
1456436
Hom.:
0
Cov.:
31
AF XY:
0.000839
AC XY:
608
AN XY:
724728
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000153
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.000284
Gnomad4 NFE exome
AF:
0.00104
Gnomad4 OTH exome
AF:
0.00138
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152228
Hom.:
0
Cov.:
33
AF XY:
0.000376
AC XY:
28
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.0000965
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000941
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000813
Hom.:
0
Bravo
AF:
0.000521
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00121
AC:
10
ExAC
AF:
0.000397
AC:
48
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00109
EpiControl
AF:
0.000771

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 27, 2022The c.694G>C (p.V232L) alteration is located in exon 3 (coding exon 3) of the BSX gene. This alteration results from a G to C substitution at nucleotide position 694, causing the valine (V) at amino acid position 232 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
19
DANN
Benign
0.88
DEOGEN2
Benign
0.023
T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.51
T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.020
T
MetaSVM
Benign
-0.68
T
MutationAssessor
Benign
-0.97
N
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.020
N
REVEL
Benign
0.20
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.069
MutPred
0.11
Gain of catalytic residue at V232 (P = 0.1236);
MVP
0.93
MPC
0.60
ClinPred
0.022
T
GERP RS
1.9
Varity_R
0.069
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199711565; hg19: chr11-122848365; API